Criterium, Inc.
Clinical trials sponsored by Criterium, Inc., explained in plain language.
-
Blood test could spot hidden breast cancer and guide Life-Saving Follow-Up therapy
Disease control Recruiting nowThis study is for people with a common type of breast cancer (ER+/HER2-) who have a high chance of the cancer coming back. Researchers will use a simple blood test to look for tiny bits of tumor DNA. If the test finds cancer DNA, participants will be randomly assigned to get eith…
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated May 26, 2026 03:19 UTC
-
New drug combo aims to stall colorectal cancer in patients Who've run out of options
Disease control Recruiting nowThis study tests whether adding TAS-102 to fruquintinib helps people with advanced colorectal cancer live longer without their disease getting worse. About 120 adults whose cancer has not responded to standard treatments will be randomly assigned to receive either the drug combo …
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
New drug cocktail aims to shrink Hard-to-Treat breast tumors
Disease control Recruiting nowThis study tests a combination of three drugs (tucatinib, eribulin, and trastuzumab) in 30 people with advanced HER2+ breast cancer that has not responded to prior treatments. The goal is to see if the combination is safe and can shrink tumors or slow cancer growth. Participants …
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC